vimarsana.com
Home
Live Updates
LifeTech Reports Steady Growth of 32.5percent in Net Profit
LifeTech Reports Steady Growth of 32.5percent in Net Profit
LifeTech Reports Steady Growth of 32.5percent in Net Profit Attributable to Owners of the Company in 2022
SHENZHEN, China, March 29, 2023 /PRNewswire/ -- LifeTech Scientific Corporation , a leading company specialized in minimally invasive interventional medical devices for... | March 29, 2023
Related Keywords
China ,
Bankura ,
Ankara ,
Turkey ,
United States ,
Shenzhen ,
Guangdong ,
Japan ,
,
Drug Administration For Compassionate ,
Lifetech Scientific Corporation Stock Code ,
Ministry Of Food ,
Aortic Arch Branch Stent Graft System ,
National Medical Products Administration ,
Lifetech Scientific Corporation The Company Or ,
Showa University Hospital ,
Aortic Branch Stent Graft System ,
Lifetech Scientific Corporation ,
Adult Congenital Heart Disease Center ,
Left Atrial Appendage ,
Congenital Heart Diseases ,
Vena Cava Filter System ,
Balloon Dilatation Catheter ,
Stent Graft System ,
Absorbable Atrial Septal Defect Closure System ,
Sizing Balloon ,
Arch Stent Graft System ,
Plus Aortic Arch Stent Graft System ,
Chimney Aortic Stent Graft System ,
Pro Aortic Stent Graft System ,
Endovascular Needle System ,
Thoracoabdominal Artery Stent Graft System ,
Iron Bioresorbable Scaffold System ,
Drug Administration ,
Prospective Multicenter Single Arm Target Study ,
Concave Supra Arch ,
Ventricular Septal Defect Occluder ,
Pediatric Heart Disease ,
Stock Code ,
Tech Scientific ,
Lifetech Scientific Corporation Stock Exchange ,
News ,
Information ,
Press Release ,
Arch ,
023 ,
Cientific ,
Corporation ,
Company ,
Specialized ,
N ,
Minimally ,
Nvasive ,
Interventional ,
Medical ,
Evices 1302 Kyg548721177 ,